Worldwide: Food, Drugs, Healthcare, Life Sciences

Stakeholders are understandably interested in assessing the extent to which the IRA will drive changes to formulary design

The Supreme Court of Appeals of West Virginia declined to decide whether West Virginia allows for public nuisance claims against distributors of prescription opioids.

The House passed the first FY26 appropriations bill (MilCon-VA) this week by a vote of 218–206.

The Supreme Court of Appeals of West Virginia declined to decide whether West Virginia allows for public nuisance claims against distributors of prescription opioids.

On June 11, 2025, was published in the DOF the "AGREEMENT recognizing as equivalent the requirements established in the Health Regulation and the technical evaluation procedures...

On June 12, 2025, BioNTech SE ("BioNTech") announced its entry into a definitive purchase agreement to acquire all shares of CureVac N.V. ("CureVac"), with an implied aggregate equity value for CureVac of approximately $1.25 billion.

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

Stakeholders are understandably interested in assessing the extent to which the IRA will drive changes to formulary design

Since the Dobbs v. Jackson Women's Health Organization decision (which overturned the landmark Roe v. Wade decision), the healthcare industry has continued to grapple with renewed concerns over patient privacy and reproductive healthcare.

A Texas federal court just shook the foundation of HIPAA's reproductive health privacy protections — but the Supreme Court may have the final word.